Geode Capital Management
RVPH

Geode Capital Management’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Geode Capital Management’s Portfolio RVPH Stock Details RVPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-72,992
Closed -$53.3K – 4543
2026
Q1 		$53.3K Buy
72,992
+20,544
+39% +$93.5K ﹤0.01% 4296
2025
Q4 		$293K Buy
52,448
+24,486
+88% +$272K ﹤0.01% 3781
2025
Q3 		$206K Buy
27,962
+5,552
+25% +$47.2K ﹤0.01% 3916
2025
Q2 		$171K Buy
22,410
+1,453
+7% +$22.6K ﹤0.01% 3925
2025
Q1 		$400K Buy
20,957
+5,372
+34% +$169K ﹤0.01% 3625
2024
Q4 		$564K Buy
15,585
+1,660
+12% +$46.2K ﹤0.01% 3561
2024
Q3 		$401K Buy
13,925
+2,119
+18% +$47.1K ﹤0.01% 3680
2024
Q2 		$302K Buy
11,806
+800
+7% +$36.4K ﹤0.01% 3763
2024
Q1 		$832K Buy
11,006
+2,066
+23% +$164K ﹤0.01% 3432
2023
Q4 		$921K Buy
8,940
+380
+4% +$34.1K ﹤0.01% 3386
2023
Q3 		$836K Buy
8,560
+1,013
+13% +$94.4K ﹤0.01% 3400
2023
Q2 		$885K Buy
7,547
+275
+4% +$34.9K ﹤0.01% 3405
2023
Q1 		$609K Hold
7,272
– – ﹤0.01% 3575
2022
Q4 		$618K Buy
7,272
+3,368
+86% +$257K ﹤0.01% 3569
2022
Q3 		$124K Sell
3,904
-130
-3% -$3.59K ﹤0.01% 4465
2022
Q2 		$88K Buy
4,034
+130
+3% +$4.55K ﹤0.01% 4635
2022
Q1 		$192K Buy
3,904
+56
+1% +$2.23K ﹤0.01% 4407
2021
Q4 		$217K Hold
3,848
– – ﹤0.01% 4441
2021
Q3 		$313K Buy
3,848
+462
+14% +$36.5K ﹤0.01% 4252
2021
Q2 		$329K Buy
+3,386
New +$341K ﹤0.01% 4125

Other funds holding RVPH

ECM
EMC Capital Management Houston, Texas $253M AUM
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
PUI
Purpose Unlimited Inc Toronto $2.62B AUM
MGI
Miller Global Investments Dallas, Texas $121M AUM
MWM
Mosley Wealth Management Anaheim, California $314M AUM

Geode Capital Management's RVPH Position: Q2 2026 in Review

Geode Capital Management sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q2 2026, closing a stake of 72,992 shares — an estimated $53.3K sold.

Geode Capital Management first reported a position in RVPH in Q2 2021 and held it in 20 quarters. The position peaked at $921K in Q4 2023. 5 funds tracked by Wall St. Rank hold RVPH as of Q2 2026.

  • Geode Capital Management reported no remaining REVIVA PHARMA HLDGS INC position as of Q2 2026 after selling out during the quarter.
  • Geode Capital Management sold 72,992 REVIVA PHARMA HLDGS INC shares in Q2 2026, an estimated $53.3K.
  • Geode Capital Management first reported a position in REVIVA PHARMA HLDGS INC in Q2 2021 and held it in 20 quarters.
  • Geode Capital Management's REVIVA PHARMA HLDGS INC position peaked at $921K in Q4 2023.
  • 5 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.